MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers
Public ClinicalTrials.gov record NCT04647240. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Two Part, Randomized Study of MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
DL-VSU-201 is a randomized, double-blind, placebo-controlled study in subjects with a non-infected venous stasis ulcer (VSU) that has failed to demonstrate improvement after receiving at least 4 weeks of standard, conventional wound therapy to evaluate the efficacy and safety of MTX-001.
Study identification
- NCT ID
- NCT04647240
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 25, 2022
- Primary completion
- Mar 30, 2027
- Completion
- May 30, 2027
- Last update posted
- Aug 25, 2026
2022 – 2027
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 02 | Tucson | Arizona | 85715 | Recruiting |
| Site 9C | Castro Valley | California | 94546 | Recruiting |
| Site 16A | Los Angeles | California | 90033 | Not yet recruiting |
| Site 9A | San Francisco | California | 94115 | Recruiting |
| Site 9B | San Francisco | California | 94117 | Recruiting |
| Site 16B | Santa Ana | California | 92704 | Not yet recruiting |
| Site 13 | Tampa | Florida | 33647 | Recruiting |
| Site 14 | Opelousas | Louisiana | 70570 | Recruiting |
| Site 04 | New Hyde Park | New York | 11042 | Recruiting |
| Site 08 | Circleville | Ohio | 43113 | Recruiting |
| Site 15 | Humble | Texas | 77338 | Recruiting |
| Site 01 | Salem | Virginia | 24153 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04647240, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 25, 2026 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04647240 live on ClinicalTrials.gov.